Literature DB >> 16344582

Cryptic gluten intolerance in type 1 diabetes: identifying suitable candidates for a gluten free diet.

D Sblattero, A Ventura, A Tommasini, L Cattin, S Martelossi, F Florian, R Marzari, A Bradbury, T Not.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16344582      PMCID： PMC1856374          DOI： 10.1136/gut.2005.077511

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

1.  Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus.

Authors:  T Not; A Tommasini; G Tonini; E Buratti; M Pocecco; C Tortul; M Valussi; G Crichiutti; I Berti; C Trevisiol; E Azzoni; E Neri; G Torre; S Martelossi; M Soban; A Lenhardt; L Cattin; A Ventura
Journal:  Diabetologia       Date:  2001-02       Impact factor: 10.122

2.  Gluten-dependent diabetes-related and thyroid-related autoantibodies in patients with celiac disease.

Authors:  A Ventura; E Neri; C Ughi; A Leopaldi; A Città; T Not
Journal:  J Pediatr       Date:  2000-08       Impact factor: 4.406

3.  Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease.

Authors:  R Marzari; D Sblattero; F Florian; E Tongiorgi; T Not; A Tommasini; A Ventura; A Bradbury
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

4.  An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients.

Authors:  G Mazzarella; M Maglio; F Paparo; G Nardone; R Stefanile; L Greco; Y van de Wal; Y Kooy; F Koning; S Auricchio; R Troncone
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

5.  Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders.

Authors:  C Sategna Guidetti; E Solerio; N Scaglione; G Aimo; G Mengozzi
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

6.  Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease.

Authors:  A Ventura; G Magazzù; L Greco
Journal:  Gastroenterology       Date:  1999-08       Impact factor: 22.682

7.  Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies.

Authors:  Anette-G Ziegler; Sandra Schmid; Doris Huber; Michael Hummel; Ezio Bonifacio
Journal:  JAMA       Date:  2003-10-01       Impact factor: 56.272

8.  In vitro-deranged intestinal immune response to gliadin in type 1 diabetes.

Authors:  Renata Auricchio; Francesco Paparo; Maria Maglio; Adriana Franzese; Francesca Lombardi; Giuliana Valerio; Gerardo Nardone; Selvaggia Percopo; Luigi Greco; Riccardo Troncone
Journal:  Diabetes       Date:  2004-07       Impact factor: 9.461

9.  Seroconversion of reticulin autoantibodies predicts coeliac disease in insulin dependent diabetes mellitus.

Authors:  M Mäki; T Huupponen; K Holm; O Hällström
Journal:  Gut       Date:  1995-02       Impact factor: 23.059
  9 in total
  4 in total

1.  The Oslo definitions for coeliac disease and related terms.

Authors:  Jonas F Ludvigsson; Daniel A Leffler; Julio C Bai; Federico Biagi; Alessio Fasano; Peter H R Green; Marios Hadjivassiliou; Katri Kaukinen; Ciaran P Kelly; Jonathan N Leonard; Knut Erik Aslaksen Lundin; Joseph A Murray; David S Sanders; Marjorie M Walker; Fabiana Zingone; Carolina Ciacci
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

2.  Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine.

Authors:  Mariantonia Maglio; Fiorella Florian; Monica Vecchiet; Renata Auricchio; Francesco Paparo; Raffaella Spadaro; Delia Zanzi; Luciano Rapacciuolo; Adriana Franzese; Daniele Sblattero; Roberto Marzari; Riccardo Troncone
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

Review 3.  Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.

Authors:  Tiina Rauhavirta; Minna Hietikko; Teea Salmi; Katri Lindfors
Journal:  Clin Rev Allergy Immunol       Date:  2019-08       Impact factor: 10.817

Review 4.  Intestinal Anti-tissue Transglutaminase2 Autoantibodies: Pathogenic and Clinical Implications for Celiac Disease.

Authors:  Mariantonia Maglio; Riccardo Troncone
Journal:  Front Nutr       Date:  2020-05-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.